article thumbnail

The Pharmacy-Transformation Offering That Restores Control To 340B Hospitals

Proxsys Rx

Additionally, its estimated that in 2024 the average 340B hospital lost nearly $3 million to unlawful drug manufacturer pricing restrictions. The Big 3s inordinate market power has enabled them to control where prescriptions are filled, and by whom eroding prescriber and hospital clinical authority. And provider incomes.

article thumbnail

Pharmacy bodies pen letter to new health secretary calling for urgent funding

The Pharmacist

Reform and investment in community pharmacy can help address the issue of waiting times for GP and hospital appointments, a group of industry bodies have told the new health and social care secretary.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Advancing Healthcare Accessibility: Point-of-Care Testing in Independent Pharmacies

Digital Pharmacist

Independent pharmacies have emerged as pivotal players in this arena, offering point-of-care testing (POCT) services that not only enhance healthcare accessibility but also alleviate the strain on hospitals and healthcare systems. Benefits of Pharmacy-Based POCT The benefits of POCT in independent pharmacies are vast.

article thumbnail

Drug Channels News Roundup, October 2021: PBMs’ Oncology Exclusions, Biosimilar Boom, BCBS vs. Hospitals, U.S. vs. the World, and CRISPR Comedy

Drug Channels

Scream as Blue Cross Blue Shield frightfully overpays hospitals Shocking! PBMs are conjuring a terrifying number of formulary exclusions for oncology drugs Eerie! Brrr.did you hear that? It’s the biosimilar boom! Believe it or not, U.S You can also find my daily posts on LinkedIn , where I have more than 20,000 followers.

article thumbnail

DCI’s Top 15 Specialty Pharmacies of 2022: Five Key Trends About Today’s Marketplace

Drug Channels

To complement that broader ranking, we rummaged around our DreamHouse to update our exclusive list of the top 15 pharmacies based on specialty drug dispensing revenues in 2022. The top three PBM-owned specialty pharmacies accounted for nearly two-thirds of prescription revenues from pharmacy-dispensed specialty drugs.

article thumbnail

Drug Channels News Roundup, February 2021: Accumulator Problems, Humana + ESI, White Bagging Battles, Buy-and-Bill Economics, and Pharmacy Hero Dave Marley

Drug Channels

In this issue: Payers confess: Patients lose from copay accumulators Humana joins the Express Scripts GPO Hospitals vs. PBMs over specialty pharmacy white bagging Let’s all follow the Buy-and-Bill Dollar! Plus, entrepreneurial pharmacy owner Dave Marley demonstrates the power of innovation. See page 15 (reproduced below).

article thumbnail

Your Hospital’s 340B Contract Pharmacy Network Is Not What It Should Be.

Proxsys Rx

Since the 2020 advent of manufacturer restrictions, while the average 340B hospital’s revenues have decreased significantly, the 340B revenue of every hospital we serve has increased. In countless instances, we’ve identified solid contract relationships with pharmacies located within walking distance of the hospitals.